Shareholders meeting

APOLLO HOSPITALS ENTERPRISE LIMITED [CIN: L85110TN1979PLC008035] Regd. Office: No.19, Bishop Gardens, Raja Annamalaipuram, Chennai – 600 028. Secretarial Dept: Ali Towers, III Floor, No.55, Greams Road, Chennai – 600 006. email: investor.relations@apollohospitals.com | Website: www.apollohospitals.com Phone: +91-44-2829 0956, 2829 3896 Board: 2829 3333 Extn. 6681 NOTICE TO THE SHAREHOLDERS Notice is hereby given that the 45th Annual General Meeting ITEM NO. 2: (AGM) of the Members of Apollo Hospitals Enterprise Confirmation of Interim Dividend and approval for Limited will be held on Tuesday, the 25th day of August, Declaration of Final Dividend. 2026 at 10.15 A.M. IST through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”) to transact the To confirm payment of Interim Dividend and to declare following business: final dividend on Equity Shares for the financial year ended March 31, 2026 and, in this regard, to pass the following ORDINARY BUSINESS: resolutions as Ordinary Resolutions: “RESOLVED THAT the Interim Dividend of ` 10/- per equity ITEM NO. 1: share (200%) of face value of ` 5/- each for the financial year 2025-26, paid to the shareholders on February 27, Adoption of Financial Statements for the financial year 2026 involving a gross amount of ` 1,437.85 million be and ended March 31, 2026. is hereby ratified.” To receive, consider and adopt:- “RESOLVED FURTHER THAT based on the i. the audited standalone financial statements of the recommendation of the Board of Directors of the Company Company for the financial year ended March 31, 2026 a Final Dividend at the rate of ` 10/- per equity share (200%) together with the reports of the Board of Directors and of face value of ` 5/- each fully paid up, be and is hereby Auditors thereon; declared, out of the profits of the Company for the financial ii. the audited consolidated financial statements of the year ended March 31, 2026.” Company for the financial year ended March 31, 2026 together with the report of the Auditors thereon; ITEM NO. 3: and in this regard, to pass the following resolutions as Re-appointment of Retiring Director. Ordinary Resolutions: To appoint a director in place of Smt. Sangita Reddy, (i) “RESOLVED THAT the audited standalone financial (DIN:00006285) who retires by rotation and being eligible statements of the Company for the financial year offers herself for re- appointment and in this regard, to pass ended March 31, 2026, and the Report of the Board the following resolution as an Ordinary Resolution: of Directors and Auditors’ thereon placed before this meeting, be and are hereby received, considered and “RESOLVED THAT pursuant to Section 152 and other adopted.” applicable provisions, if any, of the Companies Act, 2013, Smt. Sangita Reddy, (holding DIN: 00006285) who retires (ii) “RESOLVED FURTHER THAT the audited by rotation at this meeting and being eligible offers herself consolidated financial statements of the Company for re-appointment, be and is hereby re- appointed as a for the financial year ended March 31, 2026, and Director of the Company, liable to retire by rotation.” the Report of the Auditors thereon placed before this meeting, be and are hereby considered and adopted.” ITEM NO. 4: in remuneration opportunity, shall be subject to further shareholder approval.” Re-appointment of Retiring Director. “RESOLVED FURTHER THAT in the event of absence To appoint a director in place of Dr. Prathap C Reddy, or inadequacy of profits in any financial year during the (DIN:00003654) who retires by rotation and being eligible tenure of office Dr. Prathap C Reddy as whole-time director offers himself for re- appointment and in this regard, to pass designated as Executive Chairman be paid minimum the following resolution as an Ordinary Resolution: remuneration as specified in Section II of Part II of Schedule “RESOLVED THAT pursuant to Section 152 and other V to the Companies Act, 2013 as in force in each financial applicable provisions, if any, of the Companies Act, 2013, year.” Dr. Prathap C Reddy, (holding DIN:00003654) who retires “RESOLVED FURTHER THAT the remuneration approved by rotation at this meeting and being eligible offers himself hereby be paid either monthly or quarterly or half yearly for re-appointment, be and is hereby re- appointed as a or otherwise as may be agreed to between Dr. Prathap C Director of the Company, liable to retire by rotation.” Reddy, Executive Chairman and the Board of Directors of the Company from time to time.” SPECIAL BUSINESS: “RESOLVED FURTHER THAT the Board be and is hereby ITEM NO. 5: authorised to do all such acts, deeds and things as may be necessary, proper or expedient to give effect to this Re-appointment of Dr. Prathap C Reddy (DIN: 00003654) resolution including authorising one or more of its directors as a Whole time Director designated as Executive and the company secretary towards filing of forms, returns Chairman for a period of two years. if any and issuing of any letters of appointment or signing To consider and, if thought fit, to pass, the following agreements and to complete other formalities required in resolution as a Special Resolution: this regard.” “RESOLVED THAT pursuant to the provisions of Sections ITEM NO.6: 196, 197, 198 and other applicable provisions, if any, read along with Schedule V to the Companies Act, 2013 Re-appointment of Smt. Rama Bijapurkar (DIN: (‘the Act’) [including any statutory modification(s) or re- 00001835) as an Independent Director of the Company. enactment(s) thereof for the time being in force] and the To consider and, if thought fit, to pass, the following Companies (Appointment and Remuneration of Managerial resolution as a Special Resolution: Personnel) Rules, 2014, as amended from time to time “RESOLVED THAT pursuant to the provisions of Sections and Regulation 17 of Securities and Exchange Board of 149, 150, 152 read with Schedule IV and other applicable India (Listing Obligations and Disclosure Requirements) provisions, if any, to the Companies Act, 2013 (“the Act”), Regulations, 2015, (“SEBI Listing Regulations), as amended (including any statutory modification(s) or amendment(s) from time to time, consent of the Company be and is hereby thereto or re-enactment(s) thereof for the time being in accorded for the re-appointment and terms of remuneration force), the Companies (Appointment and Qualifications of of Dr. Prathap C Reddy (holding DIN: 00003654), liable to Directors) Rules, 2014 and Regulations 17, 25 and any other retire by rotation as a Wholetime Director designated as applicable provisions of the Securities and Exchange Board Executive Chairman of the Company for a further period of India (Listing Obligations and Disclosure Requirements) of two years with effect from June 25, 2026 upto June 24, Regulations, 2015 (“SEBI Listing Regulations”), as amended 2028 as recommended by the Nomination & Remuneration from time to time and the Articles of Association of the Committee and approved by the Board of Directors, upon Company, Smt. Rama Bijapurkar (holding DIN:00001835), the terms and conditions as set out in the Explanatory who was appointed as an Independent Director of Statement annexed to this Notice, with authority to the the Company for a term of five (5) consecutive years Board of Directors (which shall be deemed to include a commencing from November 12, 2021 up to November Committee of the Board) to alter and vary the terms and 11, 2026 and being eligible for re-appointment as an conditions of the said re-appointment and remuneration Independent Director has given her consent along with the in such manner as may be agreed between the Board of declaration that she meets the criteria for independence as Directors and Dr. Prathap C. Reddy, provided that any provided in Section 149(6) of the Act along with the rules material deviation from the terms set out in the Explanatory framed thereunder and Regulation 16(1)(b) of the SEBI Statement annexed to [Showing first 8,000 characters — download PDF for full document]